Dr Brett Manley, Consultant Neonatologist and CI in the CRE in Newborn medicine, published results of The Hunter Trail in New England Journal of Medicine

Dr Brett Manly consultant Neonatologist and CI in the CRE in Newborn medicine led the Hunter trial which looked at the use of a simpler and more gentle breathing support, nasal high-flow therapy - small prongs placed in the baby’s nose and gently attached to their cheeks –assessing it as a first-line treatment for these babies in their first 24 hours of life, as opposed to the more well-established breathing support of nasal Continuous Positive Airway Pressure (CPAP), which uses larger prongs fitted into the baby’s nose and tubing strapped to a special hat that the baby must wear. The findings of the study were published in the New England Journal of Medicine. You can read more about this study here.